Telomere maintenance mechanisms and cellular immortalization

Current Opinion in Genetics and Development

Volumn 9, Issue 1, 1999, Pages 97-103

  Colgin, Lorel M ^a   Reddel, Roger R ^a  

^a CHILDREN'S MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

RIBONUCLEOPROTEIN; TELOMERASE;

CELL DIVISION; CELL IMMORTALIZATION; CELL LEVEL; CELL PROLIFERATION; DNA REPAIR; DNA STRAND BREAKAGE; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; SOMATIC CELL; TELOMERE;

EID: 0033062578     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(99)80014-8     Document Type: Article

References (100)

1. Blackburn EH, Gall JG A tandemly repeated sequence at the termini of the extrachromosomal ribosomal RNA genes in Tetrahymena. J Mol Biol. 120:1978;33-53.
2. Makarov VL, Hirose Y, Langmore JP Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening. Cell. 88:1997;657-666.
3. Wright WE, Tesmer VM, Huffman KE, Levene SD, Shay JW Normal human chromosomes have long G-rich telomeric overhangs at one end. Genes Dev. 11:1997;2801-2809.
4. Olovnikov AM Principle of marginotomy in template synthesis of polynucleotides. Doklady Akademii Nauk SSR. 201:1971;1496-1499.
5. Watson JD Origin of concatemeric T7 DNA. Nat New Biol. 239:1972;197-201.
6. Wellinger RJ, Ethier K, Labrecque P, Zakian VA Evidence for a new step in telomere maintenance. Cell. 85:1996;423-433.
7. Adams AK, Holm C Specific DNA replication mutations affect telomere length in Saccharomyces cerevisiae. Mol Cell Biol. 16:1996;4614-4620.
8. Fan X, Price CM Coordinate regulation of G- and C strand length during new telomere synthesis. Mol Biol Cell. 8:1997;2145-2155.
9. Biessmann H, Mason JM, Ferry K, d'Hulst M, Valgeirsdottir K, Traverse KL, Pardue M-L Addition of telomere-associated HeT DNA sequences 'heals' broken chromosome ends in Drosophila. Cell. 61:1990;663-673.
10. Biessmann H, Champion LE, O'Hair M, Ikenaga K, Kasravi B, Mason JM Frequent transpositions of Drosophila melanogaster HeT-A transposable elements to receding chromosome ends. EMBO J. 11:1992;4459-4469.
11. Roth CW, Kobeski F, Walter MF, Biessmann H Chromosome end elongation by recombination in the mosquito Anopheles gambiae. Mol Cell Biol. 17:1997;5176-5183.
12. - senescence. Cell. 73:1993;347-360.
13. McEachern MJ, Blackburn EH Cap-prevented recombination between terminal telomeric repeat arrays (telomere CPR) maintains telomeres in Kluyveromyces lactis lacking telomerase. Genes Dev. 10:1996;1822-1834.
14. Harley CB Telomere loss: mitotic clock or genetic time bomb? Mutat Res. 256:1991;271-282.
15. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR Telomerase catalytic subunit homologs from fission yeast and human. Science. 277:1997;955-959.
16. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Dickinson Caddle S, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Qet al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell. 90:1997;785-795.
17. Kilian A, Bowtell DDL, Abud HE, Hime GR, Venter DJ, Keese PK, Duncan EL, Reddel RR, Jefferson RA Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet. 6:1997;2011-2019.
18. Harrington L, Zhou W, McPhail T, Oulton R, Yeung DSK, Mar V, Bass MB, Robinson MO Human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes Dev. 11:1997;3109-3115.
19. Greider CW, Blackburn EH Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell. 43:1985;405-413.
20. Lingner J, Hughes TR, Shevchenko A, Mann M, Lundblad V, Cech TR Reverse transcriptase motifs in the catalytic subunit of telomerase. Science. 276:1997;561-567.
21. Counter CM, Meyerson M, Eaton EN, Weinberg RA The catalytic subunit of yeast telomerase. Proc Natl Acad Sci USA. 94:1997;9202-9207.
22. Collins K, Gandhi L The reverse transcriptase component of theTetrahymena telomerase ribonucleoprotein complex. Proc Natl Acad Sci USA. 95:1998;8485-8490. The authors report cloning of a Tetrahymena telomerase protein with reverse transcriptase motifs, p133, by using a degenerate PCR strategy. p133 co-immunoprecipitates with the previously identified telomerase proteins p80 and p95. Telomerase RNA and p133 are sufficient for telomerase activity when expressed in rabbit reticulocyte lysates, although recombinant p133 plus RNA has lower processivity than native enzyme.
23. Bryan TM, Sperger JM, Chapman KB, Cech TR Telomerase reverse transcriptase genes identified in Tetrahymena thermophila and Oxytricha trifallax. Proc Natl Acad Sci USA. 95:1998;8479-8484. A description of the cloning of the Tetrahymena and Oxytricha TERT genes. The TERT mRNA level in Tetrahymena increases greatly at the point in the life cycle when de novo macronuclear telomere formation occurs. A new sequence motif conserved among ciliated protozoan TERTs is identified.
24. Greenberg RA, Allsopp RC, Chin L, Morin GB, DePinho RA Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene. 16:1998;1723-1730. The mouse TERT (mTERT) cDNA is here cloned and found localized to the short arm of chromosome 13. mTERT is expressed at low levels in most adult mouse tissues. Unlike hTERT, mTERT mRNA is detectable in primary cell cultures and is not upregulated following escape from crisis.
25. Nugent CI, Lundblad V The telomerase reverse transcriptase: components and regulation. Genes Dev. 12:1998;1073-1085.
26. Feng J, Funk WD, Wang S-S, Weinrich SL, Avilion AA, Chiu C-P, Adams RR, Chang E, Allsopp RC, Yu JHet al. The RNA component of human telomerase. Science. 269:1995;1236-1241.
27. Harrington L, McPhail T, Mar V, Zhou W, Oulton R, Bass MB, Arruda I, Robinson MO A mammalian telomerase-associated protein. Science. 275:1997;973-977.
28. Nakayama J-I, Saito M, Nakamura H, Matsuura A, Ishikawa F TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell. 88:1997;1-20.
29. Collins K, Kobayashi R, Greider CW Purification of Tetrahymena telomerase and cloning of genes encoding the two protein components of the enzyme. Cell. 81:1995;677-686.
30. Greene EC, Shippen DE Developmentally programmed assembly of higher order telomerase complexes with distinct biochemical and structural properties. Genes Dev. 12:1998;2921-2931. During the vegetative stage of the Euplotes crassus life cycle, telomerase exists as a 280 kDa complex. Macronuclear development involves de novo synthesis of telomeres and coincides with assembly of telomerase complexes of 550, 1600, and 5000 kDa. These larger complexes differ from the smaller complex in their structural and biochemical properties.
31. Ulaner GA, Hu J-F, Vu TH, Giudice LC, Hoffman AR Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res. 58:1998;4168-4172. RT-PCR is used to detect hTER, and hTERT mRNA containing none, one, or both of the α and β deletions in human fetal heart, liver and kidney. Expression of 'full-length' hTERT (i.e. containing neither of these deletions), but not hTER expression, correlated with telomerase activity. Telomerase activity and full-length hTERT expression disappeared at later stages of kidney development but β deletion transcripts persisted for longer.
32. Beattie TL, Zhou W, Robinson MO, Harrington L Reconstitution of human telomerase activity in vitro. Curr Biol. 8:1998;177-180. Human telomerase activity is here reconstituted in reticulocyte lysates with hTERT and hTER. Substitution of conserved aspartates in hTERT reverse transcriptase catalytic core abolishes this activity. Nucleotides 10-159 of hTER are sufficient for activity.
33. Nakayama J, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, Nakanishi T, Ide T, Ishikawa F Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet. 18:1998;65-68. Transfection of hTERT cDNA into normal human fibroblasts induces telomerase activity, indicating that hTERT protein is the only missing factor for telomerase activity in these cells. Mutant hTERT proteins containing substitutions at amino acid residues highly conserved in reverse transcriptases fail to induce activity, consistent with the conclusion that hTERT is the telomerase reverse transcriptase subunit.
34. Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, Holt SE, Bodnar AG, Lichtsteiner S, Kim NW, Trager JBet al. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet. 17:1997;498-502. First demonstration of the reconstitution of human telomerase activity by expression of hTER and hTERT in rabbit reticulocyte lysates, providing direct evidence that hTERT is the catalytic component of telomerase. Transient expression of hTERT cDNA in normal human diploid fibroblasts induces telomerase enzymatic activity, indicating that hTERT expression is limiting for telomerase activity in these cells.
35. Counter CM, Meyerson M, Eaton EN, Ellisen LW, Dickinson Caddle S, Haber DA, Weinberg RA Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene. 16:1998;1217-1222. Expression of HA-tagged hTERT protein in telomerase-negative GM847 (SV40-immortalized; ALT) and WI38 (normal fibroblast) cells induces levels of telomerase activity comparable to telomerase-positive immortalized cells. The authors conclude that synthesis of the hTERT subunit is the rate-limiting determinant of telomerase activity in these cells.
36. Wen J, Cong Y-S, Bacchetti S Reconstitution of wild-type or mutant telomerase activity in telomerase negative immortal human cells. Hum Mol Genet. 7:1998;1137-1141. The authors demonstrate that telomerase activity can be induced in hTER-negative, telomerase-negative immortalized ALT cell lines by transduction with expression constructs for both hTERT and hTER. Use of a construct encoding hTER with a mutated template region results in expression of a telomerase enzyme that synthesizes mutant telomeric sequences.
37. Li H, Zhao L-L, Funder JW, Liu J-P Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells. J Biol Chem. 272:1997;16729-16732.
38. Ku W-C, Cheng A-J, Wang T-CV Inhibition of telomerase activity by PKC inhibitors in human nasopharyngeal cancer cells in culture. Biochem Biophys Res Comm. 241:1997;730-736.
39. Bodnar AG, Kim NW, Effros RB, Chiu C-P Mechanism of telomerase induction during T cell activation. Exp Cell Res. 228:1996;58-64.
40. Li H, Zhao L, Yang Z, Funder JW, Liu J-P Telomerase is controlled by protein kinase Ca in human breast cancer cells. J Biol Chem. 273:1998;33436-33442. hTEP1 and hTERT are phosphorylated in vivo, and are physically associated with protein kinase Cα. Phosphorylation of partially purified telomerase causes a marked increase in telomerase activity in vitro.
41. Wang J, Xie LY, Allan S, Beach D, Hannon GJ Myc activates telomerase. Genes Dev. 12:1998;1769-1774. Myc induces telomerase expression in both normal human mammary epithelial cells (HMECs) and diploid fibroblasts, and extends the replicative lifespan of HMECs. This report suggests a link between oncogenic transformation and extended proliferative potential caused by telomere maintenance.
42. Cong Y-S, Wen J, Bacchetti S: The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum Mol Genet 1999, in press. A description of the cloning of hTERT from a BAC library, determination of intron/exon boundaries, and sequencing of the hTERT upstream region. Several transcription factor binding sites are identified in the promoter including two myc sites.
43. Bryan TM, Englezou A, Dunham MA, Reddel RR Telomere length dynamics in telomerase-positive immortal human cell populations. Exp Cell Res. 239:1998;370-378.
44. Jones CJ, Soley A, Skinner JW, Gupta J, Haughton MF, Wyllie FS, Schlumberger M, Bacchetti S, Wynford-Thomas D Dissociation of telomere dynamics from telomerase activity in human thyroid cancer cells. Exp Cell Res. 240:1998;333-339.
45. Martens UM, Zijlmans JM, Poon SS, Dragowska W, Yui J, Chavez EA, Ward RK, Lansdorp PM Short telomeres on human chromosome 17p. Nat Genet. 18:1998;76-80.
46. Zhong Z, Shiue L, Kaplan S, de Lange T A mammalian factor that binds telomeric TTAGGG repeats in vitro. Mol Cell Biol. 12:1992;4834-4843.
47. Smith S, de Lange T TRF1, a mammalian telomeric protein. Trends Genet. 13:1997;21-26.
48. Griffith J, Bianchi A, de Lange T TRF1 promotes parallel pairing of telomeric tracts in vitro. J Mol Biol. 278:1998;79-88. Electron microscopy and mass analysis suggests that dimers and tetramers of the telomere-specific TRF1 protein bind to hexanucleotide tandem repeats. The authors also show that two telomeric tracts tend to exhibit parallel pairing along a TRF1-covered segment.
49. van Steensel B, de Lange T Control of telomere length by the human telomeric protein TRF1. Nature. 385:1997;740-743.
50. Broccoli D, Smogorzewska A, Chong L, de Lange T Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat Genet. 17:1997;231-235.
51. van Steensel B, Smogorzewska A, de Lange T TRF2 protects human telomeres from end-to-end fusions. Cell. 92:1998;401-413. Expression of a dominant negative mutant of the telomere-binding protein TRF2 in a human telomerase-positive fibrosarcoma cell line induced loss of telomeric G-rich strand overhangs, end-to-end fusion of telomeres, and a rapid senescence-like growth arrest. Suggests that TRF2 may protect chromosome ends by maintaining the correct structure at telomeric termini, and raises the possibility that senescence of normal cells may be associated with loss of TRF2 from shortened telomeres.
52. LaBranche H, Dupuis S, Ben-David Y, Bani M-R, Wellinger RJ, Chabot B Telomere elongation by hnRNP A1 and a derivative that interacts with telomeric repeats and telomerase. Nat Genet. 19:1998;199-202.
53. Weaver DT Telomeres: moonlighting by DNA repair proteins. Curr Biol. 8:1998;R492-R494.
54. Bertuch A, Lundblad V Telomeres and double-strand breaks: trying to make ends meet. Trends Cell Biol. 8:1998;339-342.
55. Gravel S, Larrivée M, Labrecque P, Wellinger RJ Yeast Ku as a regulator of chromosomal DNA end structure. Science. 280:1998;741-744. In yeast, 3′ overhangs at the ends of telomeres are normally present only during S phase but in strains lacking Ku these overhangs are longer and present throughout the cell cycle. The authors also show via in vivo crosslinking experiments that yeast Ku protein binds telomeric DNA. In addition, functional Ku is required for cell survival in the absence of telomerase activity.
56. Porter SE, Greenwell PW, Ritchie KB, Petes TD The DNA-binding protein Hdf1p (a putative Ku homologue) is required for maintaining normal telomere length in Saccharomyces cerevisiae. Nucleic Acids Res. 24:1996;582-585.
57. Boulton SJ, Jackson SP Identification of a Saccharomyces cerevisiae Ku80 homologue: roles in DNA double strand break rejoining and in telomeric maintenance. Nucleic Acids Res. 24:1996;4639-4648.
58. Polotnianka RM, Li J, Lustig AJ The yeast Ku heterodimer is essential for protection of the telomere against nucleolytic and recombinational activities. Curr Biol. 8:1998;831-834. Ku genes are involved in double strand break repair and, in mammals, V(D)J recombination. This paper reports that mutations in yeast Ku increase the length of 3′ overhangs on telomeres and cause loss of the cell-cycle dependence of overhangs. Ku mutants also show chromosomal instability. Genetic analyses indicate that Ku interacts with the single-stranded telomeric DNA binding protein Cdc13p.
59. Laroche T, Martin SG, Gotta M, Gorham HC, Pryde FE, Louis EJ, Gasser SM Mutation of yeast Ku genes disrupts the subnuclear organization of telomeres. Curr Biol. 8:1998;653-656. Deletion of either the yeast Ku70 or Ku80 genes disrupts the normal clustering of telomeres and causes dispersion of the telomere-specific binding protein, Rap1p. The telomere-associated silencing factors, Sir3p and Sir4p, are also dispersed and telomeric silencing is lost. The Ku proteins are implicated in the spatial organization of telomeres within the nucleus.
60. Nugent CI, Bosco G, Ross LO, Evans SK, Salinger AP, Moore JK, Haber JE, Lundblad V Telomere maintenance is dependent on activities required for end repair of double-strand breaks. Curr Biol. 8:1998;657-660. Yeast Ku is identified as a third epistasis group required for telomere maintenance. The other two groups contain telomerase and the single-stranded DNA-binding protein Cdc13p. Although the Rad50/Mre11/Xrs2 complex is required along with Ku for double strand break repair, it is in the telomerase epistasis group for telomere maintenance. The authors suggest that telomere termini are identified by the cell as double-strand breaks but that there are mechanisms for preventing their 'repair'.
61. Boulton SJ, Jackson SP Components of the Ku-dependent non homologous end-joining pathway are involved in telomeric length maintenance and telomeric silencing. EMBO J. 17:1998;1819-1828. Yeast cells deficient in Ku are unable to silence a URA3 gene placed at the telomere. TEL1 - a homolog of DNA-PK, which complexes with Ku to function in mammalian DSB repair - is not involved in telomeric silencing or yeast Ku-dependent DSB repair. The authors also show that the yeast RAD50/MRE11/XRS2 complex and Ku have different roles in DSB repair, and although the Rad50 complex is needed for telomere maintenance, it has little effect on silencing.
62. Tsubouchi H, Ogawa H A novel mre11 mutation impairs processing of double-strand breaks of DNA during both mitosis and meiosis. Mol Cell Biol. 18:1998;260-268.
63. Nugent CI, Hughes TR, Lue NF, Lundblad V Cdc13p: a single-strand telomeric DNA binding protein with a dual role in yeast telomere maintenance. Science. 274:1996;249-252.
64. 1-3 telomeric DNA-binding protein in vitro that affects telomere behavior in vivo. Proc Natl Acad Sci USA. 93:1996;13760-13765.
65. Broccoli D, Young JW, de Lange T Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA. 92:1995;9082-9086.
66. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S Telomerase activity in normal leukocytes and in hematologic malignancies. Blood. 85:1995;2315-2320.
67. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, Shay JW, Ishioka S, Yamakido M Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol. 155:1995;3711-3715.
68. Härle-Bachor C, Boukamp P Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA. 93:1996;6476-6481.
69. Yasumoto S, Kunimura C, Kikuchi K, Tahara H, Ohji H, Yamamoto H, Ide T, Utakoji T Telomerase activity in normal human epithelial cells. Oncogene. 13:1996;433-439.
70. Hsiao R, Sharma HW, Ramakrishnan S, Keith E, Narayanan R Telomerase activity in normal human endothelial cells. Anticancer Res. 17:1997;827-832.
71. Weng N-P, Hathcock KS, Hodes RJ Regulation of telomere length and telomerase in T and B cells: a mechanism for maintaining replicative potential. Immunity. 9:1998;151-157. A review of the current understanding of telomere-length regulation in T and B cells. Of special interest is the finding of telomerase activity capable of maintaining telomere lengths in germinal center B cells.
72. Morin GB The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell. 59:1989;521-529.
73. Girardi AJ, Jensen FC, Koprowski H SV40-induced transformation of human diploid cells: crisis and recovery. J Cell Comp Physiol. 65:1965;69-84.
74. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11:1992;1921-1929.
75. Klingelhutz AJ, Barber SA, Smith PP, Dyer K, McDougall JK Restoration of telomeres in human papillomavirus-immortalized human anogenital epithelial cells. Mol Cell Biol. 14:1994;961-969.
76. Counter CM, Botelho FM, Wang P, Harley CB, Bacchetti S Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol. 68:1994;3410-3414.
77. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J. 14:1995;4240-4248.
78. Counter CM, Hahn WC, Wei W, Dickinson Caddle S, Beijersbergen RL, Lansdorp PM, Sedivy JM, Weinberg RA Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc Natl Acad Sci USA. 95:1998;14723-14728. Expression of hTERT cDNA in SV40-transformed, pre-crisis (non-immortalized) human embryonic kidney cells results in telomere maintenance, and allows cells to continue growing without entering crisis. hTERT that is modified by the addition of a hemagglutinin epitope tag at its carboxyl terminus does not prevent telomere shortening, even though it is active in the in vitro TRAP assay and cells expressing this form of hTERT do enter crisis.
79. Murnane JP, Sabatier L, Marder BA, Morgan WF Telomere dynamics in an immortal human cell line. EMBO J. 13:1994;4953-4962.
80. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med. 3:1997;1271-1274. A demonstration that a mechanism for alternative lengthening of telomeres (ALT), characterized by telomeres of heterogeneous length (ranging from short to very long) and absence of detectable telomerase activity, is present in some tumor-derived cell lines and tumors. ALT is therefore not confined to cell lines immortalized in vitro.
81. Henderson S, Allsopp R, Spector D, Wang S-S, Harley C In situ analysis of changes in telomere size during replicative aging and cell transformation. J Cell Biol. 134:1996;1-12.
82. Lansdorp PM, Poon S, Chavez E, Dragowska V, Zijlmans M, Bryan T, Reddel R, Egholm M, Bacchetti S, Martens U Telomeres in the hematopoietic system. Ciba Found Symp. 211:1997;209-218.
83. Tokutake Y, Matsumoto T, Watanabe T, Maeda S, Tahara H, Sakamoto S, Niida H, Sugimoto M, Ide T, Furuichi Y Extra-chromosome telomere repeat DNA in telomerase-negative immortalized cell lines. Biochem Biophys Res Commun. 247:1998;765-772.
84. Ogino H, Nakabayashi K, Suzuki M, Takahashi E, Fujii M, Suzuki T, Ayusawa D Release of telomeric DNA from chromosomes in immortal human cells lacking telomerase activity. Biochem Biophys Res Commun. 248:1998;223-227.
85. Blasco MA, Lee H-W, Hande MP, Samper E, Lansdorp PM, DePinho RA, Greider CW Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell. 91:1997;25-34.
86. Ramakrishnan S, Eppenberger U, Mueller H, Shinkai Y, Narayanan R Expression profile of the putative catalytic subunit of the telomerase gene. Cancer Res. 58:1998;622-625.
87. Kolquist KA, Ellisen LW, Counter CM, Meyerson M, Tan LK, Weinberg RA, Haber DA, Gerald WL Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nat Genet. 19:1998;182-186.
88. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL, Shay JW Specific association of human telomerase activity with immortal cells and cancer. Science. 266:1994;2011-2015.
89. Nakabayashi K, Ogata T, Fujii M, Tahara H, Ide T, Wadhwa R, Kaul SC, Mitsui Y, Ayusawa D Decrease in amplified telomeric sequences and induction of senescence markers by introduction of human chromosome 7 or its segments in SUSM-1. Exp Cell Res. 235:1997;345-353.
90. Horikawa I, Oshimura M, Barrett JC Repression of the telomerase catalytic subunit by a gene on human chromosome 3 that induces cellular senescence. Mol Carcinog. 22:1998;65-72.
91. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu C-P, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE Extension of life-span by introduction of telomerase into normal human cells. Science. 279:1998;349-352. Stable expression of exogenous hTERT cDNA in telomerase-negative normal retinal pigment epithelial cells and foreskin fibroblasts induces telomerase activity. A normal karyotype is maintained and cells exceed their normal replicative lifespan by at least 20 population doublings. These findings demonstrate that telomerase activity permits escape from senescence.
92. Vaziri H, Benchimol S Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol. 8:1998;279-282. Retrovirus-mediated expression of hTERT in normal human diploid fibroblasts results in telomerase activity and telomere maintenance in these cells and extends replicative lifespan for at least 26 population doublings, demonstrating that telomerase activity permits escape from senescence.
93. Morales CP, Holt SE, Ouellette M, Kaur KJ, Yan Y, Wilson KS, White MA, Wright WE, Shay JW: Lack of cancer-associated changes in human fibroblasts after immortalization with telomerase. Nat Genet 1999, in press. hTERT-transfected fibroblasts proliferate for at least 200 population doublings more than the controls. Cell-cycle checkpoints activated by low serum concentration, confluence, and UV-B irradiation appear to be intact. As shown previously by others in normal cells, oncogenic ras is able to induce a senescence-like state. The frequency of karyotypic abnormalities was not greater than that seen in late-passage normal cells.
94. Jiang X-R, Jimenez G, Chang E, Frolkis M, Kusler B, Sage M, Beeche M, Bodnar AG, Wahl GM, Tlsty TD, Chiu C-P: Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Genet 1999, in press. At twice the normal number of population doublings, human fibroblasts and retinal pigment epithelial cells expressing hTERT cDNA are able to undergo growth arrest in response to low-serum concentration, confluence, and cell-cycle blocking chemicals. The cells retain anchorage dependence.
95. Reddel R: A reassessment of the telomere hypothesis of senescence. Bioessays 1999, in press.
96. Newbold RF Genetic control of telomerase and replicative senescence in human and rodent cells. Ciba Found Symp. 211:1997;177-189.
97. Carman TA, Afshari CA, Barrett JC Cellular senescence in telomerase-expressing syrian hamster embryo cells. Exp Cell Res. 244:1998;33-42. Syrian hamster embryo cells were found to express telomerase and to undergo senescence even though their telomeres had not shortened. The data suggest that the mitotic clock in these cells does not involve telomere shortening.
98. INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature. 396:1998;84-88. The authors show that induction of telomerase activity is not sufficient to immortalize human keratinocyte or mammary epithelial cells. Inactivation of the pRb/p16 pathway - but not p53 or p19ARF - is an additional equirement for hTERT-induced lifespan extension in these cells.
99. INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts. Mol Cell Biol. 15:1995;4745-4753.
100. Lieber MR, Grawunder U, Wu X, Yaneva M Tying loose ends: roles of Ku and DNA-dependent protein kinase in the repair of double-strand breaks. Curr Opin Genet Dev. 7:1997;99-104.